azd3241 and Peritonitis

azd3241 has been researched along with Peritonitis* in 1 studies

Other Studies

1 other study(ies) available for azd3241 and Peritonitis

ArticleYear
Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO).
    Bioorganic & medicinal chemistry, 2020, 06-15, Volume: 28, Issue:12

    Myeloperoxidase (MPO) activity and subsequent generation of hypochlorous acid has been associated with the killing of host-invading microorganisms (e.g. bacteria, viruses, and fungi). However, during oxidative stress, high MPO activity can damage host tissue and is linked to several chronic inflammatory conditions. Herein, we describe the development of a novel biaryl, indole-pyrazole series of irreversible mechanism-based inhibitors of MPO. Derived from an indole-containing high-throughput screen hit, optimization efforts resulted in potent and selective 6-substituted indoles with good oral bioavailability and in vivo activity.

    Topics: Animals; Enzyme Inhibitors; Half-Life; Indoles; Mice; Peritonitis; Peroxidase; Pyrazoles; Structure-Activity Relationship

2020